ARNA Genomics careers

ARNA Breast Cancer (ARNA BC) - first in line of early stage cancer detection tests.

• Test is based on standard DNA amplification using rt-PCR
machine.
• Test is performed within 4 hours with extremely low cost of sales.
• Anticipated very low market price (depending on
the market fixed costs).
• Unique technology of direct DNA-from-plasma amplification
avoiding prior DNA extraction thus dramatically increasing
technology sensitivity.
• Proprietary technology for detection of “hot spots” in human
genome. Breast cancer test involves panel of 6 gene fragments
with increased quantities in blood of positive patients which
allows to detect major breast cancer biological subtypes:
Luminal A, Luminal B, Her2 / neu and Triple-negative, as well as
differentiate them from benign tumors.
• Ongoing R&D process for other types of cancer with positive
outlook.